Improvement of Dissolution Properties of Etoricoxib through Solid Dispersion Technique

Solid dispersion, Etoricoxib, Solvent evaporation method

Authors

  • Suripeddi Muralidhar Professor & HOD, Department of Pharmaceutics, Vikas Institute of Pharmaceutical Sciences, Nidagatla, Rajahmundry-533102.
  • Taneeru Venkata Narayana Director & HOD Department of Pharmacology, Vikas Institute of Pharmaceutical Sciences, Nidagatla, Rajahmundry-533102.
  • Gindi Sumalatha Principal, Vikas Institute of Pharmaceutical Sciences, Nidagatla, Rajahmundry-533102.
  • Ramya k. Assistant Professor, Department of Pharmaceutics,Vikas Institute of Pharmaceutical Sciences, Nidagatla, Rajahmundry-533102.
June 4, 2022

Downloads

Etoricoxib, a non-steroidal anti-inflammatory drug, is used to Osteoarthritis, Rheumatoid arthritis and Acute Gouty arthritis. Etoricoxib is practically insoluble in water; hence present study was carried out to enhance dissolution properties of Etoricoxib through the preparation of Solid Dispersions using Mannitol, PEG 6000 and PVP K30 as carriers at various proportions by using Solvent Evaporation Method. The drug release profile was studied in 0.1N HCl containing 0.75 % SLS. U.V. Spectrophotometric method was selected for assay as well as in-vitro dissolution studies at 234nm. The FTIR used to characterize the solid state of solid dispersions.  All the solid dispersions exhibited superior dissolution than pure drug. The drug dissolution studies followed first order kinetics.